PTPRC and inflammatory bowel disease: Macrophage depletion with clodronate led to significant attenuation of CD45+ cells in both CONT-CLOD and IBD-CLOD groups, although significantly more CD45+ cells persisted post-clodronate in CONT-CLOD.